Title of article :
Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action
Author/Authors :
Kumar Arun, Jagdish School of Pharmaceutical Sciences - Jaipur National University - Jagatpura - Jaipur - Rajasthan-302 017 - India , Vodeti, Rajeshwar School of Pharmacy - ANURAG Group of Institutions - Venkatapur (V) - Ghatkesar (M) Medchal (Dist.) - Hyderabad - Telangana-500 038, India - School of Pharmaceutical Sciences - Jaipur National University - Jagatpura - Jaipur - Rajasthan-302 017 - India , Shrivastava, Birendra School of Pharmaceutical Sciences - Jaipur National University - Jagatpura - Jaipur - Rajasthan-302 017 - India , Bakshi, Vasudha School of Pharmacy - ANURAG Group of Institutions - Venkatapur (V) - Ghatkesar (M) Medchal (Dist.) - Hyderabad - Telangana-500 038, India
Abstract :
Purpose: The present work endeavors to report a systematic approach of developing the lipidic
self-nanoemulsifying formulation of olmesartan medoxomil (OMT) on the principles of Quality
by Design (QbD).
Methods: For preparing the self-nanoemulsifying formulation, a mixture of oil, surfactant and
cosurfactant were used as vehicles. The excipients were selected after screening by solubility
as well as pseudoternary phase titration studies. Mixture design was adopted for systematic
optimization of the composition of nanolipidic formulations, which were evaluated for smaller
globule size, stable zeta potential and lower values of polydispersity index. The optimized
liquid self-nanoemulsifying formulation was identified using numerical and graphical
optimization techniques, followed by validation of the experimental model. Solidification of
self-nanoemulsifying formulation was carried out using porous carriers, and then optimized
on the basis of oil adsorption potential, powder flow property and drug release performance.
Pharmacokinetic study was performed in male Wistar rats for evaluating the drug absorption
parameters. All the experimental data obtained were subjected to statistical analysis using oneway
ANOVA followed by post hoc analysis using Student’s t test.
Results: The optimized liquid self-nanoemulsifying formulation showed globule size <100 nm,
emulsification efficiency <5 minutes and in vitro drug release >85% within in 30 minutes.
Further, the solid SNEDDS formulation was effectively formulated using Neusilin US2 with
maximum oil adsorption capacity and good micromeritic properties. Pharmacokinetic
evaluation indicated 4 to 5-folds increase (P < 0.05) in the values of Cmax, AUC, and reduction in
Tmax from the nanoformulations vis-à-vis the marketed formulation.
Conclusion: Overall, the developed nanolipidic formulation of olmesartan indicated superior
efficacy in augmenting the drug dissolution and absorption performance.
Keywords :
Bioavailability , Nanoemulsion , Optimization , Experimental design , Pharmacokinetics
Journal title :
Advanced Pharmaceutical Bulletin